scPharmaceuticals Inc.

3.20
-0.08 (-2.44%)
At close: Mar 03, 2025, 3:59 PM
3.23
0.94%
After-hours: Mar 03, 2025, 04:27 PM EST

scPharmaceuticals Statistics

Share Statistics

scPharmaceuticals has 50.04M shares outstanding. The number of shares has increased by 38.79% in one year.

Shares Outstanding 50.04M
Shares Change (YoY) 38.79%
Shares Change (QoQ) 0.02%
Owned by Institutions (%) 80.02%
Shares Floating 34.09M
Failed to Deliver (FTD) Shares 20
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 6.27M, so 12.54% of the outstanding shares have been sold short.

Short Interest 6.27M
Short % of Shares Out 12.54%
Short % of Float 18.16%
Short Ratio (days to cover) 14.21

Valuation Ratios

The PE ratio is -4.41 and the forward PE ratio is -3.03. scPharmaceuticals's PEG ratio is -0.58.

PE Ratio -4.41
Forward PE -3.03
PS Ratio 17.77
Forward PS 0.6
PB Ratio 6.49
P/FCF Ratio -4.07
PEG Ratio -0.58
Financial Ratio History

Enterprise Valuation

scPharmaceuticals Inc. has an Enterprise Value (EV) of 281.75M.

EV / Earnings -5.14
EV / Sales 20.73
EV / EBITDA -6.12
EV / EBIT -5.09
EV / FCF -4.75

Financial Position

The company has a current ratio of 7.08, with a Debt / Equity ratio of 1.08.

Current Ratio 7.08
Quick Ratio 6.4
Debt / Equity 1.08
Total Debt / Capitalization 51.97
Cash Flow / Debt -1.47
Interest Coverage -6.82

Financial Efficiency

Return on equity (ROE) is -1.47% and return on capital (ROIC) is -71.49%.

Return on Equity (ROE) -1.47%
Return on Assets (ROA) -0.58%
Return on Capital (ROIC) -71.49%
Revenue Per Employee $100,688.89
Profits Per Employee $-406,000
Employee Count 135
Asset Turnover 0.14
Inventory Turnover 0.43

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -46.41% in the last 52 weeks. The beta is 0.1, so scPharmaceuticals's price volatility has been higher than the market average.

Beta 0.1
52-Week Price Change -46.41%
50-Day Moving Average 3.38
200-Day Moving Average 4.11
Relative Strength Index (RSI) 45.35
Average Volume (20 Days) 358.48K

Income Statement

In the last 12 months, scPharmaceuticals had revenue of 13.59M and earned -54.81M in profits. Earnings per share was -1.42.

Revenue 13.59M
Gross Profit 9.78M
Operating Income -55.4M
Net Income -54.81M
EBITDA -46.06M
EBIT -55.4M
Earnings Per Share (EPS) -1.42
Full Income Statement

Balance Sheet

The company has 46.81M in cash and 40.27M in debt, giving a net cash position of 6.54M.

Cash & Cash Equivalents 46.81M
Total Debt 40.27M
Net Cash 6.54M
Retained Earnings -281.35M
Total Assets 125.07M
Working Capital 108.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -59.24M and capital expenditures -40K, giving a free cash flow of -59.28M.

Operating Cash Flow -59.24M
Capital Expenditures -40K
Free Cash Flow -59.28M
FCF Per Share -1.54
Full Cash Flow Statement

Margins

Gross margin is 71.96%, with operating and profit margins of -407.53% and -403.22%.

Gross Margin 71.96%
Operating Margin -407.53%
Pretax Margin -403.22%
Profit Margin -403.22%
EBITDA Margin -338.86%
EBIT Margin -407.53%
FCF Margin -436.14%

Dividends & Yields

SCPH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -43.29%
FCF Yield -36.12%
Dividend Details

Analyst Forecast

The average price target for SCPH is $15, which is 357.3% higher than the current price. The consensus rating is "Buy".

Price Target $15
Price Target Difference 357.3%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score -3.45
Piotroski F-Score 2